Genetic association of the GDNF alpha-receptor genes with schizophrenia and clozapine response

Journal of Psychiatric Research

Volumn 44, Issue 11, 2010, Pages 700-706

  Souza, Renan P ^a,b,c   Romano Silva, Marco A ^a   Lieberman, Jeffrey A ^d   Meltzer, Herbert Y ^e   MacNeil, Lesley T ^f,g   Culotti, Joseph G ^f,g   Kennedy, James L ^b,c   Wong, Albert H C ^b,c,g  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^e VANDERBILT UNIVERSITY   (United States)

^f MOUNT SINAI HOSPITAL   (Canada)

^g UNIVERSITY OF TORONTO   (Canada)

Author keywords

Clozapine response; Family based association test; GDNF; GFR alpha; GFRA; Schizophrenia

Indexed keywords

CLOZAPINE; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR RECEPTOR; GFRA1 PROTEIN, HUMAN; GFRA2 PROTEIN, HUMAN; GFRA3 PROTEIN, HUMAN; GFRA4 PROTEIN, HUMAN; NEUROLEPTIC AGENT;

ADULT; ARTICLE; CHROMOSOME; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; FEMALE; GENE LOCATION; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GFRA1 GENE; GFRA2 GENE; GFRA3 GENE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIGENE FAMILY; PRIORITY JOURNAL; RECEPTOR GENE; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT RESPONSE; CASE CONTROL STUDY; FAMILY HEALTH; GENE LINKAGE DISEQUILIBRIUM; GENETICS; GENOTYPE; PHARMACOGENETICS; PROCEDURES;

ADULT; ANTIPSYCHOTIC AGENTS; CASE-CONTROL STUDIES; CLOZAPINE; FAMILY HEALTH; FEMALE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR RECEPTORS; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; PHARMACOGENETICS; POLYMORPHISM, GENETIC; SCHIZOPHRENIA;

EID: 77954624706     PISSN: 00223956     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2010.01.002     Document Type: Article

References (54)

1. Aickin M. Other method for adjustment of multiple testing exists. BMJ 1999, 318:127-128.
2. Angelucci F., Aloe L., Gruber S.H., Fiore M., Mathe A.A. Chronic antipsychotic treatment selectively alters nerve growth factor and neuropeptide Y immunoreactivity and the distribution of choline acetyl transferase in rat brain regions. International Journal of Neuropsychopharmacology 2000, 3:13-25.
3. Arranz M.J., de Leon J. Pharmacogenetics and pharmacogenomics of schizophrenia: a review of last decade of research. Molecular Psychiatry 2007, 12:707-747.
4. Badner J.A., Gershon E.S. Meta-analysis of whole-genome linkage scans of bipolar disorder and schizophrenia. Molecular Psychiatry 2002, 7:405-411.
5. Balding D.J. A tutorial on statistical methods for population association studies. Nature Review Genetics 2006, 7:781-791.
6. Baloh R.H., Tansey M.G., Lampe P.A., Fahrner T.J., Enomoto H., Simburger K.S., et al. Artemin, a novel member of the GDNF ligand family, supports peripheral and central neurons and signals through the GFRalpha3-RET receptor complex. Neuron 1998, 21:1291-1302.
7. Barrett J.C., Fry B., Maller J., Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21:263-265.
8. Beck K.D., Valverde J., Alexi T., Poulsen K., Moffat B., Vandlen R.A., et al. Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain. Nature 1995, 373:339-341.
9. Bender R., Lange S. Multiple test procedures other than Bonferroni's deserve wider use. BMJ 1999, 318:600-601.
10. Bozzi Y., Borrelli E. Absence of the dopamine D2 receptor leads to a decreased expression of GDNF and NT-4 mRNAs in restricted brain areas. European Journal of Neuroscience 1999, 11:1275-1284.
11. Burke R.E. GDNF as a candidate striatal target-derived neurotrophic factor for the development of substantia nigra dopamine neurons. Journal of Neural Transmission Supplement 2006, 41-45.
12. Chen A.C., Eisch A.J., Sakai N., Takahashi M., Nestler E.J., Duman R.S. Regulation of GFRalpha-1 and GFRalpha-2 mRNAs in rat brain by electroconvulsive seizure. Synapse 2001, 39:42-50.
13. Chlan-Fourney J., Ashe P., Nylen K., Juorio A.V., Li X.M. Differential regulation of hippocampal BDNF mRNA by typical and atypical antipsychotic administration. Brain Research 2002, 954:11-20.
14. Choi-Lundberg D.L., Lin Q., Chang Y.N., Chiang Y.L., Hay C.M., Mohajeri H., et al. Dopaminergic neurons protected from degeneration by GDNF gene therapy. Science 1997, 275:838-841.
15. Colavita A., Krishna S., Zheng H., Padgett R.W., Culotti J.G. Pioneer axon guidance by UNC-129, a C. elegans TGF-beta. Science 1998, 281:706-709.
16. DerSimonian R., Laird N. Meta-analysis in clinical trials. Controlled Clinical Trials 1986, 7:177-188.
17. Duman R.S. Synaptic plasticity and mood disorders. Molecular Psychiatry 2002, 7(Suppl. 1):S29-S34.
18. Durrant C., Zondervan K.T., Cardon L.R., Hunt S., Deloukas P., Morris A.P. Linkage disequilibrium mapping via cladistic analysis of single-nucleotide polymorphism haplotypes. American Journal of Human Genetics 2004, 75:35-43.
19. Enokido Y., de Sauvage F., Hongo J.A., Ninkina N., Rosenthal A., Buchman V.L., et al. GFR alpha-4 and the tyrosine kinase Ret form a functional receptor complex for persephin. Current Biology 1998, 8:1019-1022.
20. Henderson C.E., Phillips H.S., Pollock R.A., Davies A.M., Lemeulle C., Armanini M., et al. GDNF: a potent survival factor for motoneurons present in peripheral nerve and muscle. Science 1994, 266:1062-1064.
21. Hisaoka K., Nishida A., Koda T., Miyata M., Zensho H., Morinobu S., et al. Antidepressant drug treatments induce glial cell line-derived neurotrophic factor (GDNF) synthesis and release in rat C6 glioblastoma cells. Journal of Neurochemistry 2001, 79:25-34.
22. Jing S., Wen D., Yu Y., Holst P.L., Luo Y., Fang M., et al. GDNF-induced activation of the ret protein tyrosine kinase is mediated by GDNFR-alpha, a novel receptor for GDNF. Cell 1996, 85:1113-1124.
23. Kazeem G.R., Farrall M. Integrating case-control and TDT studies. Annals of Human Genetics 2005, 69:329-335.
24. Klein R.D., Sherman D., Ho W.H., Stone D., Bennett G.L., Moffat B., et al. A GPI-linked protein that interacts with Ret to form a candidate neurturin receptor. Nature 1997, 387:717-721.
25. Lavedan C., Licamele L., Volpi S., Hamilton J., Heaton C., Mack K., et al. Association of the NPAS3 gene and five other loci with response to the antipsychotic iloperidone identified in a whole genome association study. Molecular Psychiatry 2009, 14:804-819.
26. Lee K., Kunugi H., Nanko S. Glial cell line-derived neurotrophic factor (GDNF) gene and schizophrenia: polymorphism screening and association analysis. Psychiatry Research 2001, 104:11-17.
27. Lewis C.M., Levinson D.F., Wise L.H., DeLisi L.E., Straub R.E., Hovatta I., et al. Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia. American Journal of Human Genetics 2003, 73:34-48.
28. Lewis D.A., Levitt P. Schizophrenia as a disorder of neurodevelopment. Annual Reviews in Neuroscience 2002, 25:409-432.
29. Lin L.F., Doherty D.H., Lile J.D., Bektesh S., Collins F. GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 1993, 260:1130-1132.
30. MacNeil L.T., Hardy W.R., Pawson T., Wrana J.L., Culotti J.G. UNC-129 regulates the balance between UNC-40 dependent and independent UNC-5 signaling pathways. Nature Neuroscience 2009, 12:150-155.
31. Masure S., Cik M., Hoefnagel E., Van der Linden I., Scott R., Van Gompel P., et al. Mammalian GFRalpha-4, a divergent member of the GFRalpha family of coreceptors for glial cell line-derived neurotrophic factor family ligands, is a receptor for the neurotrophic factor persephin. Journal of Biological Chemistry 2000, 275:39427-39434.
32. Michelato A., Bonvicini C., Ventriglia M., Scassellati C., Randazzo R., Bignotti S., et al. 3' UTR (AGG)n repeat of glial cell line-derived neurotrophic factor (GDNF) gene polymorphism in schizophrenia. Neuroscience Letters 2004, 357:235-237.
33. Millar J.K., Wilson-Annan J.C., Anderson S., Christie S., Taylor M.S., Semple C.A., et al. Disruption of two novel genes by a translocation co-segregating with schizophrenia. Human Molecular Genetics 2000, 9:1415-1423.
34. Nanobashvili A., Airaksinen M.S., Kokaia M., Rossi J., Asztely F., Olofsdotter K., et al. Development and persistence of kindling epilepsy are impaired in mice lacking glial cell line-derived neurotrophic factor family receptor alpha 2. Proceedings of the National Academy of Sciences 2000, 97:12312-12317.
35. Nash B., Colavita A., Zheng H., Roy P.J., Culotti J.G. The forkhead transcription factor UNC-130 is required for the graded spatial expression of the UNC-129 TGF-beta guidance factor in C. elegans. Genes and Development 2000, 14:2486-2500.
36. Ng M.Y., Levinson D.F., Faraone S.V., Suarez B.K., DeLisi L.E., Arinami T., et al. Meta-analysis of 32 genome-wide linkage studies of schizophrenia. Molecular Psychiatry 2009, 14:774-785.
37. Nicodemus K.K. Catmap: case-control, TDT meta-analysis package. BMC Bioinformatics 2008, 9:130.
38. Nielsen D.M., Ehm M.G., Weir B.S. Detecting marker-disease association by testing for Hardy-Weinberg disequilibrium at a marker locus. American Journal of Human Genetics 1998, 63:1531-1540.
39. Owen M.J., Craddock N., O'Donovan M.C. Schizophrenia: genes at last?. Trends in Genetics 2005, 21:518-525.
40. Perneger T.V. What's wrong with Bonferroni adjustments. BMJ 1998, 316:1236-1238.
41. Ritchie M.D., Hahn L.W., Roodi N., Bailey L.R., Dupont W.D., Parl F.F., et al. Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer. American Journal of Human Genetics 2001, 69:138-147.
42. Sanicola M., Hession C., Worley D., Carmillo P., Ehrenfels C., Walus L., et al. Glial cell line-derived neurotrophic factor-dependent RET activation can be mediated by two different cell-surface accessory proteins. Proceedings of the National Academy of Sciences USA 1997, 94:6238-6243.
43. Schwab S.G., Knapp M., Mondabon S., Hallmayer J., Borrmann-Hassenbach M., Albus M., et al. Support for association of schizophrenia with genetic variation in the 6p22.3 gene, dysbindin, in sib-pair families with linkage and in an additional sample of triad families. American Journal of Human Genetics 2003, 72:185-190.
44. Shao Z., Dyck L.E., Wang H., Li X.M. Antipsychotic drugs cause glial cell line-derived neurotrophic factor secretion from C6 glioma cells. Journal of Psychiatry and Neuroscience 2006, 31:32-37.
45. Souza R.P., Romano-Silva M.A., Lieberman J.A., Meltzer H.Y., Wong A.H., Kennedy J.L. Association study of GSK3 gene polymorphisms with schizophrenia and clozapine response. Psychopharmacology (Berlin) 2008, 200:177-186.
46. Stefansson H., Thorgeirsson T.E., Gulcher J.R., Stefansson K. Neuregulin 1 in schizophrenia: out of Iceland. Molecular Psychiatry 2003, 8:639-640.
47. Straub R.E., Jiang Y., MacLean C.J., Ma Y., Webb B.T., Myakishev M.V., et al. Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia. American Journal of Human Genetics 2002, 71:337-348.
48. Takahashi M., Shirakawa O., Toyooka K., Kitamura N., Hashimoto T., Maeda K., et al. Abnormal expression of brain-derived neurotrophic factor and its receptor in the corticolimbic system of schizophrenic patients. Molecular Psychiatry 2000, 5:293-300.
49. Tomac A., Lindqvist E., Lin L.F., Ogren S.O., Young D., Hoffer B.J., et al. Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo. Nature 1995, 373:335-339.
50. Treanor J.J., Goodman L., de Sauvage F., Stone D.M., Poulsen K.T., Beck C.D., et al. Characterization of a multicomponent receptor for GDNF. Nature 1996, 382:80-83.
51. Trikalinos T.A., Salanti G., Khoury M.J., Ioannidis J.P. Impact of violations and deviations in Hardy-Weinberg equilibrium on postulated gene-disease associations. American Journal of Epidemiology 2006, 163:300-309.
52. Trupp M., Belluardo N., Funakoshi H., Ibanez C.F. Complementary and overlapping expression of glial cell line-derived neurotrophic factor (GDNF), c-ret proto-oncogene, and GDNF receptor-alpha indicates multiple mechanisms of trophic actions in the adult rat CNS. Journal of Neuroscience 1997, 17:3554-3567.
53. Williams H.J., Norton N., Peirce T., Dwyer S., Williams N.M., Moskvina V., et al. Association analysis of the glial cell line-derived neurotrophic factor (GDNF) gene in schizophrenia. Schizophrenia Research 2007, 97:271-276.
54. Wittke-Thompson J.K., Pluzhnikov A., Cox N.J. Rational inferences about departures from Hardy-Weinberg equilibrium. American Journal of Human Genetics 2005, 76:967-986.